Rankings/PharmD Capital Trading with PharmD_KS
PharmD Capital Trading with PharmD_KS
by PharmD_KS
Discretionary Trader providing commentary and opinions on various asset classes. ES/SPX/SPY specialist, long term investor, and medium-term L/S equities swing trader.
Free subscribers
~6.0k
Est. revenue
$270k – $510k / yr
Last 30 days
Mostly flat
Public estimates are rounded ranges, not exact figures. Paid plans include precise metrics, history charts, sponsor intel, and exports. Last updated Nov 3, 2026.
More in Finance
Citrini Research
~267k subs · $5.3M – $8.8M / yr
InvirtiendoME Roberto Chamorro
~9.0k subs · $4.5M – $7.5M / yr
Compounding Quality
~536k subs · $3.8M – $6.3M / yr
Capital Flows
~62k subs · $2.9M – $4.9M / yr
The Running Of The Bulltards
~17k subs · $2.2M – $3.6M / yr
Key Context by Tae Kim
~13k subs · $1.5M – $2.5M / yr
How They Make Money
~370k subs · $1.4M – $2.3M / yr
TMT Breakout
~17k subs · $1.2M – $2.0M / yr
Free Substats Weekly
Every Friday: breakout publications, revenue milestones, and what moved in the Substack economy. No account required.
Want the full dataset? View paid plans.
Want the full picture on PharmD Capital Trading with PharmD_KS?
Upgrade for subscriber history charts, sponsor details, cross-publication search, exports, and alerts. Public pages show rounded estimates only. Developers: MCP setup · Pro ($100/mo) includes the full platform, Friday email, and MCP for Cursor.
Already have an account? Sign in to upgrade